FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060976580> ?p ?o ?g. }

• W2060976580 endingPage "49" @default.
• W2060976580 startingPage "40" @default.
• W2060976580 abstract "Objective The outcomes of patients with squamous cell carcinoma of the anal canal treated by either sphincter-preserving procedures or radical surgery were evaluated, with the goals of identifying factors predicting treatment failure and quantifying results of salvage therapy in patients with recurrent disease. Basic Procedures A population-based study on all patients in all 159 hospitals of the Department of Veterans Affairs (VA) from 1987 to 1991 was carried out. Data were compiled from several national computerized VA data sets. Supplementary information from local tumor registrars also was obtained, including demographic information, discharge summaries, operative reports, pathology reports, and medical oncology and radiation oncology summaries. From these sources, information on tumor histology, tumor stage, tumor grade, presence of regional or distant metastases, surgical procedures, use of chemotherapy and radiation therapy (RT), toxicity of chemotherapy and RT, development of recurrent disease, treatment of recurrence, survival, and cause of death were obtained. Main Findings Four hundred five patients with anal cancer were identified by computer search, and 204 (51 %) were evaluable; 164 of 204 (80%) had squamous cell carcinoma, 137 of whom (84%) were treated with sphincter-preserving procedures, and 27 of whom (16%) were treated by by radical surgery. One hundred fourteen of 138 (83%) were treated by multimodality therapy, which we defined as local excision followed by chemotherapy and RT. The mean dose of RT among patients treated by multimodality therapy was 4200 ± 540 cGy and 82% of those treated with multimodality therapy received 5-FU/mitomycin C. Recurrent disease was diagnosed in 43 of all 149 patients (29%) with potentially curable disease. (stages I-III) Multivariate analysis revealed that stage at diagnosis (p = 0.04) and method of treatment (p = 0.03) were the sole predictors of recurrence. Fifty-three percent of patients who underwent salvage abdominoperineal resection (APR) are alive, whereas only 19% who underwent salvage chemotherapy with or without RT are alive. Principal Conclusions These data indicate that multimodality therapy currently is being employed in the majority of patients with squamous cell carcinoma of the anal canal in the VA system. Tumor stage and" @default.
• W2060976580 created "2016-06-24" @default.
• W2060976580 creator A5004458262 @default.
• W2060976580 creator A5033372637 @default.
• W2060976580 creator A5041269335 @default.
• W2060976580 creator A5052662893 @default.
• W2060976580 creator A5059161716 @default.
• W2060976580 creator A5073064147 @default.
• W2060976580 date "1994-07-01" @default.
• W2060976580 modified "2023-10-04" @default.
• W2060976580 title "Recurrent Squamous Cell Carcinoma of the Anal Canal Predictors of Initial Treatment Failure and Results of Salvage Therapy" @default.
• W2060976580 cites W1973209464 @default.
• W2060976580 cites W1974234666 @default.
• W2060976580 cites W1986961933 @default.
• W2060976580 cites W1989570585 @default.
• W2060976580 cites W1990455666 @default.
• W2060976580 cites W1994330604 @default.
• W2060976580 cites W1997200014 @default.
• W2060976580 cites W1997612130 @default.
• W2060976580 cites W2004367809 @default.
• W2060976580 cites W2005118109 @default.
• W2060976580 cites W2015515099 @default.
• W2060976580 cites W2018963841 @default.
• W2060976580 cites W2020296791 @default.
• W2060976580 cites W2021598219 @default.
• W2060976580 cites W2025289696 @default.
• W2060976580 cites W2027310670 @default.
• W2060976580 cites W2037783145 @default.
• W2060976580 cites W2040945842 @default.
• W2060976580 cites W2041601737 @default.
• W2060976580 cites W2052910344 @default.
• W2060976580 cites W2055544524 @default.
• W2060976580 cites W2056455081 @default.
• W2060976580 cites W2067126590 @default.
• W2060976580 cites W2069640589 @default.
• W2060976580 cites W2080875502 @default.
• W2060976580 cites W2081562563 @default.
• W2060976580 cites W2086667503 @default.
• W2060976580 cites W2111698785 @default.
• W2060976580 cites W2150172425 @default.
• W2060976580 cites W2159646213 @default.
• W2060976580 cites W2317077328 @default.
• W2060976580 cites W2401627852 @default.
• W2060976580 cites W2402640364 @default.
• W2060976580 cites W2408888135 @default.
• W2060976580 cites W2409293733 @default.
• W2060976580 cites W2429727814 @default.
• W2060976580 cites W2443808981 @default.
• W2060976580 cites W2474205938 @default.
• W2060976580 cites W4290158845 @default.
• W2060976580 cites W2399573093 @default.
• W2060976580 cites W2413116564 @default.
• W2060976580 doi "https://doi.org/10.1097/00000658-199407000-00007" @default.
• W2060976580 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1234285" @default.
• W2060976580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8024357" @default.
• W2060976580 hasPublicationYear "1994" @default.
• W2060976580 type Work @default.
• W2060976580 sameAs 2060976580 @default.
• W2060976580 citedByCount "95" @default.
• W2060976580 countsByYear W20609765802012 @default.
• W2060976580 countsByYear W20609765802013 @default.
• W2060976580 countsByYear W20609765802014 @default.
• W2060976580 countsByYear W20609765802015 @default.
• W2060976580 countsByYear W20609765802016 @default.
• W2060976580 countsByYear W20609765802017 @default.
• W2060976580 countsByYear W20609765802018 @default.
• W2060976580 countsByYear W20609765802019 @default.
• W2060976580 countsByYear W20609765802020 @default.
• W2060976580 countsByYear W20609765802022 @default.
• W2060976580 countsByYear W20609765802023 @default.
• W2060976580 crossrefType "journal-article" @default.
• W2060976580 hasAuthorship W2060976580A5004458262 @default.
• W2060976580 hasAuthorship W2060976580A5033372637 @default.
• W2060976580 hasAuthorship W2060976580A5041269335 @default.
• W2060976580 hasAuthorship W2060976580A5052662893 @default.
• W2060976580 hasAuthorship W2060976580A5059161716 @default.
• W2060976580 hasAuthorship W2060976580A5073064147 @default.
• W2060976580 hasBestOaLocation W20609765802 @default.
• W2060976580 hasConcept C121608353 @default.
• W2060976580 hasConcept C126322002 @default.
• W2060976580 hasConcept C141071460 @default.
• W2060976580 hasConcept C143998085 @default.
• W2060976580 hasConcept C146357865 @default.
• W2060976580 hasConcept C151730666 @default.
• W2060976580 hasConcept C195910791 @default.
• W2060976580 hasConcept C2775969662 @default.
• W2060976580 hasConcept C2776694085 @default.
• W2060976580 hasConcept C2776874909 @default.
• W2060976580 hasConcept C2779840525 @default.
• W2060976580 hasConcept C2780035688 @default.
• W2060976580 hasConcept C2781074409 @default.
• W2060976580 hasConcept C2908647359 @default.
• W2060976580 hasConcept C4441509 @default.
• W2060976580 hasConcept C509974204 @default.
• W2060976580 hasConcept C71924100 @default.
• W2060976580 hasConcept C86803240 @default.
• W2060976580 hasConcept C99454951 @default.
• W2060976580 hasConceptScore W2060976580C121608353 @default.

• next